Evidence map›Paper›PMID 14762167›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2004

B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Victoria E H Wang, Dean Tantin, Jianzhu Chen, Phillip A Sharp

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Octamer transcription factor 1 mediates epithelial-mesenchymal transition in colorectal cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Article
  4. Article
  5. OCT-1 overexpression is associated with poor prognosis in patients with well-differentiated gastric cancer.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Article
  6. Article
  7. Article
  8. Octamer-binding transcription factors: genomics and functions.Frontiers in bioscience (Landmark edition) · 2013
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Victoria E H WangDepartment of Biology and Center for Cancer Research and McGovern Institute, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, MA 02139-4307, USA.
Dean Tantin
Jianzhu Chen
Phillip A Sharp

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
USE OF RETROVIRUS PROMOTER TRAP VECTORS TO IDENTIFY ONCOGENES AND ANTI-ONCOGENESP01CA042063 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI JACKS, TYLER E. · 1986 to 2021
$30.5M
NCI NIH HHS P01 CA042063NCI NIH HHS P01-CA42063NCI NIH HHS P30 CA014051NCI NIH HHS P30-CA14051PHS HHS A140416
6 · The paper itself

Abstract

The POU domain transcription factors Oct-1 and Oct-2 interact with the octamer element, a motif conserved within Ig promoters and enhancers, and mediate transcription from the Ig loci. Inactivation of Oct-2 by gene targeting results in normal B cell development and Ig transcription. To study the role of Oct-1 in these processes, the lymphoid compartment of RAG-1(-/-) animals was reconstituted with Oct-1-deficient fetal liver hematopoietic cells. Recipient mice develop B cells with levels of surface Ig expression comparable with wild type, although at slightly reduced numbers. These B cells transcribe Ig normally, respond to antigenic stimulation, undergo class switching, and use a normal repertoire of light chain variable segments. However, recipient mice show slight reductions in serum IgM and IgA. Thus, the Oct-1 protein is dispensable for B cell development and Ig transcription.

Indexed as

Adoptive TransferAnimalsB-LymphocytesCell DivisionCell Line, TransformedDNA-Binding ProteinsEmbryo, MammalianGene DeletionGene Expression RegulationGenes, RAG-1Host Cell Factor C1Immunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulinsMiceMice, KnockoutDNA-Binding ProteinsHcfc1 protein, mouseHost Cell Factor C1Immunoglobulin Heavy ChainsImmunoglobulin Light ChainsImmunoglobulinsOctamer Transcription Factor-1Pou2f1 protein, mouseTranscription Factors

Identifiers

PMID14762167
PMCPMC357042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.